SCOPUS 정보 검색 플랫폼

Movement Disorders

Volumn 15, Issue 5, 2000, Pages 873-878

Beneficial effects of amantodine on L-dopa-induced dyskinesias in Parkinson's disease

(2) Saint Cyr, Jean A a,b,c,e Trépanier, Lisa L c,d,e

a UNIVERSITY OF TORONTO (Canada)

b UNIVERSITY OF TORONTO (Canada)

c UNIVERSITY HEALTH NETWORK (Canada)

d YORK UNIVERSITY (Canada)

e TORONTO WESTERN HOSPITAL (Canada)

Author keywords

Amantadine; Dyskinesias; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; APOMORPHINE; BENSERAZIDE; BROMOCRIPTINE; ENTACAPONE; LEVODOPA; MADOPAR LT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PERGOLIDE; PLACEBO; TOLCAPONE; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DYSKINESIA; DYSTONIA; EDEMA; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SELF REPORT; HOSPITALIZATION; MIDDLE AGED; TREATMENT OUTCOME;

AGED; AMANTADINE; ANTIPARKINSON AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0033626282 PISSN: 08853185 EISSN: None Source Type: Journal
DOI: 10.1002/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-I Document Type: Article

Times cited : (205)

References (31)

1
- 0023026069
- Low dose L-dopa therapy in Parkinson's disease: A 6 year follow-up study
- (1986) Neurology , vol.36 , pp. 1528-1530
- Poewe, W.¹ Lees, A.J.² Stern, G.M.³

2
- 0031770529
- Young-onset Parkinson's disease revisited-clinical features, natural history, and mortality
- (1998) Mov Disord , vol.13 , pp. 885-894
- Schrag, A.¹ Ben-Shlomo, Y.² Brown, R.³ Marsden, C.D.⁴ Quinn, N.⁵

3
- 0027342793
- Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients
- (1993) Adv Neurol , vol.60 , pp. 656-659
- Poewe, W.¹ Kleedorfer, B.² Wagner, M.³ Boesch, S.⁴ Schelosky, L.⁵

4
- 0031923068
- Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease
- (1998) J Neurol Neurosurg Psychiatry , vol.64 , pp. 573-576
- Colzi, A.¹ Turner, K.² Lees, A.J.³

5
- 0023937322
- Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism
- (1988) Ann Neurol , vol.24 , pp. 87-89
- Sage, J.I.¹ Trooskin, S.² Sonsalla, P.K.³ Heikkila, R.⁴ Duvoisin, R.C.⁵

6
- 0031906233
- Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
- (1998) Mov Disord , vol.13 , pp. 336-338
- Syed, N.¹ Murphy, L.² Zimmerman T., Jr.³ Mark, M.H.⁴ Sage, J.I.⁵

7
- 0030922767
- Posteroventral medial pallidotomy in advanced Parkinson's disease
- (1997) N Engl J Med , vol.337 , pp. 1036-1042
- Lang, A.E.¹ Lozano, A.M.² Montgomery, E.³ Duff, J.⁴ Tasker, R.⁵ Hutchinson, W.⁶

8
- 0028864745
- Effect of GPi pallidotomy on motor function in Parkinson's disease
- (1995) Lancet , vol.346 , pp. 1383-1386
- Lozano, A.M.¹ Lang, A.E.² Galvez-Jimenez, N.³

9
- 0031882299
- Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease
- (1998) Brain , vol.121 , pp. 451-457
- Krack, P.¹ Pollak, P.² Limousin, P.³

10
- 0031935016
- Opposite motor effects of pallidal stimulation in Parkinson's disease
- (1998) Ann Neurol , vol.43 , pp. 180-192
- Krack, P.¹ Pollack, P.² Limousin, P.³

11
- 0032531683
- Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
- (1998) N Engl J Med , vol.339 , pp. 1105-1111
- Limousin, P.¹ Krack, P.² Pollack, P.³

12
- 0031566830
- Chronic stimulation of subthalamic nucleus improves levodopa induced dyskinesias in Parkinson's disease
- (1997) Lancet , vol.350 , pp. 1676
- Krack, P.¹ Limousin, P.² Benabid, A.L.³ Pollack, P.⁴

13
- 0032692741
- From off-period dystonia to peak-dose chorea: The clinical spectrum of varying subthalamic nucleus activity
- (1999) Brain , vol.122 , pp. 1133-1146
- Krack, P.¹ Pollack, P.² Limousin, P.³ Benazzouz, A.⁴ Deuschl, G.⁵ Benabid, A.L.⁶

14
- 0025801041
- Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA receptor gated ion channel: A human postmortem brain study
- (1991) Eur J Pharmacol , vol.206 , pp. 297-300
- Kornhuber, J.¹ Bormann, J.² Hubers, M.³ Rusche, K.⁴ Riederer, P.⁵

15
- 0029148215
- Therapeutic brain concentration of the NMDA receptor antagonist amantadine
- (1995) Neuropharmacology , vol.34 , pp. 713-721
- Kornhuber, J.¹ Quack, G.² Danysz, W.³

16
- 0026607343
- The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way
- (1992) Eur J Pharmacol , vol.213 , pp. 439-443
- Stoof, J.C.¹ Booij, J.² Drukarch, B.³ Wolters, E.C.⁴

17
- 0031689728
- Amantadine reduces levodopa induced dyskinesias in parkinsonian monkeys
- (1998) Mov Disord , vol.13 , pp. 798-802
- Blanchet, P.J.¹ Konitsiotis, S.² Chase, T.N.³

18
- 0001713077
- Amantadine ameliorates levodopa induced dyskinesias
- (1997) Neurology , vol.48 , pp. 328
- Rajput, A.H.¹ Uitti, R.J.² Lang, A.E.³ Rajput, A.H.⁴

19
- 0006647256
- Amantadine as treatment for dyskinesia and motor fluctuations in Parkinson's disease
- (1998) Neurology. , vol.50 , pp. 1323-1326
- Verhagen Metman, L.¹ Del Dotto, P.² van den Munckhof, P.³ Fang, J.⁴ Mouradian, M.M.⁵ Chase, T.N.⁶

20
- 0028084737
- Levodopa-induced dyskinesias in Parkinson's disease, phenomenology and pathophysiology
- (1994) Mov Disord , vol.9 , pp. 2-12
- Marconi, R.¹ Lefebre-Caparros, D.² Bonnet, A.M.³ Vidailhet, M.⁴ Dubois, B.⁵ Agid, Y.⁶

21
- 0000224448
- and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease, Florham Park, NJ: MacMillan Healthcare Information
- (1987) , vol.2 , pp. 153-163
- Fahn, S.¹ Elton, R.L.²

22
- 0023639778
- Amantadine and motor fluctuations in chronic Parkinson's disease
- (1987) Clin Neuropharmacol , vol.10 , pp. 522-526
- Shannon, K.M.¹ Goetz, C.G.² Carroll, V.S.³ Tanner, C.M.⁴ Klawans, H.L.⁵

23
- 0029689447
- Contribution of dopaminergic and glutaminergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease
- (1996) Adv Neurol , vol.69 , pp. 497-501
- Chase, T.N.¹ Engber, T.M.² Mouradian, M.M.³

24
- 0025845919
- Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate
- (1991) Mov Disord , vol.6 , pp. 133-138
- Brotchie, J.M.¹ Mitchell, I.J.² Sambrook, M.A.³ Crossman, A.R.⁴

25
- 0029665122
- Levodopa induced dyskinesias improved by a glutaminergic antagonist in parkinsonian monkeys
- (1996) Ann Neurol , vol.39 , pp. 574-578
- Papa, S.M.¹ Chase, T.N.²

26
- 0028556522
- NMDA receptor blockade reverses motor response alterations induced by levodopa
- (1994) Neuroreport , vol.5 , pp. 2586-2588
- Engber, T.M.¹ Papa, S.M.² Boldry, R.C.³ Chase, T.N.⁴

27
- 0028232327
- Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist in rodent and primate models of Parkinson's disease
- (1994) Ann Neurol , vol.35 , pp. 655-661
- Greenamyre, J.T.¹ Eller, R.V.² Zhang, Z.³

28
- 0031975428
- Blockade of glutaminergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease
- (1998) Amino Acids , vol.14 , pp. 75-82
- Verhagen-Metman, L.¹ Del Dotto, P.² Blanchet, P.J.³ van den Munckhof, P.⁴ Chase, T.N.⁵

29
- 0002581639
- Effect of memantine on Parkinson's disease: A controlled double blind prospective randomized study
- [Abstract]
- (1998) Mov Disord , vol.13 , Issue.SUPPL. 2 , pp. 46
- Merello, M.¹ Nouzeilles, M.I.² Cammarota, A.³

30
- 0033594792
- Riluzole for levodopa induced dyskinesias in advanced Parkinson's disease
- (1999) Lancet , vol.353 , pp. 1764-1765
- Merims, D.¹ Ziv, I.² Djaldetti, R.³ Melamed, E.⁴

31
- 0031739073
- Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease
- (1998) Mov Disord , vol.13 , pp. 871-876
- Brotchie, J.M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.